New #Stocks to Watch at Investor Ideas: (Nasdaq: $BFRI) (Nasdaq: $CGTX) (Nasdaq: $EXAI) (CSE: $PBF.C) (CSE: $STGX.C) (CSE: $MJEM.C)

 New #Stocks to Watch at Investor Ideas: (Nasdaq: $BFRI) (Nasdaq: $CGTX) (Nasdaq: $EXAI) (CSE: $PBF.C) (CSE: $STGX.C) (CSE: $MJEM.C)

 

#Biotech, #Mining, #Plant-Based and #Tech Stocks to Watch

 

 

 

 

 

 

 

 

 

 

 

 

Point Roberts WA, Delta BC, January 14, 2022 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Mining, Plant-Based and Tech. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at https://www.investorideas.com/news/2022/main/01141Stocks.asp

 

The newest biotech companies are involved in treatments of dermatological conditions, CNS and cancer among other diseases.

 

The latest mining company is focused on cobalt and ‘green metals’, while the newest plant-based company offers a vegan meat alternative derived from hemp.

 

The newest tech company is a social media company for Generation Z’s.

 

New stocks added to the Biotech Stock Directory:

Biofrontera Inc.                      (Nasdaq: BFRI) is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.

 

COGNITION THERAPEUTICS INC (Nasdaq: CGTX) is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system, or CNS, and retina. Our goal is to develop disease modifying treatments for patients with these degenerative disorders by initially leveraging our expertise in the σ-2 (sigma-2) receptor, or S2R, which is expressed by multiple cell types, including neuronal synapses, and acts as a key regulator of cellular damage commonly associated with certain age-related degenerative diseases of the CNS and retina. We believe that targeting the S2R complex represents a mechanism that is functionally distinct from other current approaches in clinical development for the treatment of degenerative diseases.

 

Exscientia Ltd. (Nasdaq: EXAI) is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline of internal and partnered programmes demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials. Exscientia has offices in Oxford, Vienna, Dundee, Miami, Boston, and Osaka

 

IO Biotech, Inc. (Nasdaq: IOBT) is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on its T-win® technology platform. The T-win® platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. IO Biotech is advancing its lead immuno-oncology candidate, IO102-IO103, targeting IDO and PD-L1, in clinical studies and its other pipeline candidates through clinical and preclinical development. IO Biotech is headquartered in Copenhagen, Denmark, and has additional offices within the United States (New York, New York and Rockville, Maryland) and United Kingdom (Monmouthshire).

 

LianBio (NasdaqGM:LIAN) is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets.

 

MiNK Therapeutics, Inc. (Nasdaq: INKT) is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. MiNK is advancing a pipeline of both native and next-generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

 

Pyxis Oncology, Inc. (Nasdaq PYXS) is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. Pyxis develops its product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Since its launch in 2019, Pyxis has developed a broad portfolio of novel antibody drug conjugate, or ADC, product candidates, and monoclonal antibody, or mAb, preclinical discovery programs that it is developing as monotherapies and in combination with other therapies.

 

Theseus Pharmaceuticals, Inc. (Nasdaq:THRX) is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. Theseus is developing next-generation tyrosine kinase inhibitors (TKIs): "pan-variant" targeted therapies that address all major drug resistance mutations. Theseus' lead product candidate, THE-630, is a pan-variant KIT inhibitor for the treatment of patients with advanced gastrointestinal stromal tumors (GIST), whose cancer has developed resistance to earlier lines of kinase inhibitor therapy. Theseus is also developing a fourth-generation, selective epidermal growth factor receptor (EGFR) inhibitor for C797S-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer (NSCLC).

 

Vaxxinity, Inc.  (NasdaqGM:VAXX) is purpose-driven biotechnology company committed to democratizing healthcare across the globe. The company is pioneering a new class of synthetic, peptide-based immunotherapeutic vaccines aimed at disrupting the existing treatment paradigm for chronic disease, increasingly dominated by monoclonal antibodies, which suffer from prohibitive costs and cumbersome administration. The company’s proprietary technology platform has enabled the innovation of novel pipeline candidates designed to bring the efficiency of vaccines to the treatment of chronic diseases, including Alzheimer’s, Parkinson’s, migraine, and hypercholesterolemia. The technology is also implemented as part of a COVID-19 vaccine program. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health.

 

New stocks added to the Mining Stocks Directory:

StrategX Elements Corp. (CSE:STGX) is an exploration company poised to be a significant contributor in the green energy sector and emerging low carbon economy. The Company is currently focused on discovery of cobalt and associated ‘green’ metals in northern Canada. The Company’s property portfolio includes two new regional plays: Project 939 & EA South situated near the shores of the East Arm of the Great Slave Lake, Northwest Territories, and Project M on the Melville peninsula, Nunavut, also located close to tidewater.

 

New stocks added to the Plant-Based Stocks Directory:

Planet Based Foods Global Inc. (CSE:PBF) is focused on producing natural, low processed and nutritional choices that are better for people and the planet. The Company currently offers a high quality, cost-efficient vegan meat alternative derived from hemp proteins including burgers, breakfast sausages, burger crumbles and sausage crumbles.

 

New stocks added to the Tech Stocks Directory:

Mijem Newcomm Tech Inc. (CSE:MJEM) is a social media and technology company providing innovative solutions to create a vibrant social marketplace for Generation Z communities, such as students, to connect and to efficiently buy, sell and trade goods and services on and off campus.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

#AI #Healthcare #Stock News: GBT (OTCPK: $GTCH) is Developing a Mobile Application for its AI Based Healthcare Advisory System; #ArtificialIntelligence

 #AI #Healthcare #Stock News: GBT (OTCPK: $GTCH) is Developing a Mobile Application for its AI Based Healthcare Advisory System; #ArtificialIntelligence

 

Enabling API connection with #healthcare providers #telemedicine platforms and enhancing overall user's experience

 

SAN DIEGO - January 4, 2022 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT" or the "Company") is now developing a mobile application for its AI empowered healthcare advisory system.

 

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2022/01041AI-Healthcare.asp

The mobile application will be working with a back-end infrastructure, enabling an efficient and user-friendly interface. The mobile application will support private accounts, with a question & answer conversation type advising system, and in future versions, natural voice support using NLP (Natural Language Processing) technology. The mobile technology will be synchronized with the system's web application for easier and intuitive user interactions. The AI health advisory system will be trained with health-related information and connected with accredited data sources, among them are the CDC (Centers for Disease Control and Prevention), NCBI (National Center for Biotechnology Information), medical text books, and other credible resources. The system is aimed to perform as a general health Q/A advisory system, providing first-line of medical advice.

 

GBT plans to further develop the system to include intelligent telemedicine capabilities that will assist patients and healthcare specialists through connected devices. The AI-driven computer program will be able to connect to healthcare providers computerized systems through an API (Application Programming Interface); effectively, establishing direct telemedicine communications. The mobile technology plans to incorporate GBT's qTerm vital device to enable real-time vital information sharing with a healthcare professional during telemedicine sessions. The mobile application will support iOS and Android platforms and is targeted to be complete during the Q2 of 2022.

 

"As a natural evolution of our AI-driven health advisory system, we are now developing its mobile application to work with full synchronization together its web interface. As with the system's web application, the mobile app will provide a conversational interface type, designed to be at the forefront of an AI program that processes the user's data. The knowledge base health advisory system will be connected to credible health-related data resources, among them are the CDC, medical text books and NCBI, to provide credible advice for general health related questions. Additionally, we plan to implement all the necessary infrastructure within the mobile application to establish future telemedicine capabilities with clinics and healthcare providers through an API interface. The mobile app architecture will include qTerm's vital device support to enable future real-time vital data sharing within telemedicine sessions. The healthcare advisory agent is aimed to provide first line health related advice and become an assistance tool for healthcare professionals. One of its major advantages is the capability to provide healthcare support for remote locations. The mobile application design is focusing on a secured communication protocol, efficient data management and user-friendly interface. The mobile app will support iOS and Android platforms, providing intelligent healthcare assistance, monitoring and telemedicine capabilities for our new healthcare era," said Danny Rittman, the Company's CTO.

 

There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched and developed, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) ("GBT") (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT's mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT's goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT's vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

  Get more tech stocks investor ideas- news, articles, podcasts and stock directories

 

 

#AI #Healthcare #Stocks to Watch: (OTCPINK: $GTCH) (NYSE: $BBLN) (NYSE: $GE) (NYSE: $PHG) @babylonhealth @GEHealthcare @PhilipsHealth

 

 

 #AI #Healthcare #Stocks to Watch: (OTCPINK: $GTCH) (NYSE: $BBLN) (NYSE: $GE) (NYSE: $PHG) @babylonhealth @GEHealthcare @PhilipsHealth

 

Adoption and Innovation of #AI #Tech in the #Healthcare Sector

 

Point Roberts WA, Vancouver BC– December 22, 2021 – Investorideas.com (https://www.investorideas.com/), a global investor news source covering Artificial Intelligence (AI) issues a sector snapshot on the role of AI in healthcare, featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).  

 

Read this article, featuring GTCH in full at https://www.investorideas.com/news/2021/artificial-intelligence/12221GTCH-BBLN-GE-PHG.asp

 

Artificial Intelligence (AI) technologies have achieved near ubiquity in everyday life and in few places is this more true than in the healthcare sector. Recent research published by Markets and Markets projects that globally the AI in Healthcare market will grow from $6.9 billion USD in 2021 to $67.4 billion by 2027. A similar report published by Allied Market Research forecasts a market size of $194.4 billion by 2030. As might be expected, much of this is driven by demands for innovation spurred on by the COVID-19 pandemic, but the former report in particular also cites the “market influx of large and complex healthcare datasets, growing need to reduce healthcare costs, improving computing power and declining hardware cost,” and more as being key factors influencing the market’s growth.

 

With regard to COVID-19 however, the following excerpt from the Allied Market Research report’s overview reads:

 

At present, AI technologies are playing a crucial role to combat the pandemic. Though the use of AI in healthcare is not a new notion, its application in the COVID-19 outbreak situation has proven its prospects in the sector. The AI tools are rapidly being used to detect & diagnose the virus and retort to the outbreak through personalized information and learning.

 

GBT Technologies Inc. (OTC PINK:GTCH), an early stage technology developer in (IoT), and Artificial Intelligence (AI) Enabled Mobile Technology Platforms, recently announced plans to implement Metaverse Technology within its Apollo (Internal Project Code Name) motion detection system. The following statement from the company outlines the technology, indicating as well its application outside of healthcare:

 

The system is based on radio waves and can detect a moving entity’s motion and stationary positions enabling an imaging technology to show these movements and positions on a computer screen in real time. Internal project code name Apollo, includes an AI technology that controls the radio waves transmission and analyzes the reflections, constructing 2D/3D images in real time.

The technology can be implemented within a wide variety of domains like health monitoring, security and computer vision. Apollo’s technology can be also used as an efficient driver’s monitoring system, detecting impaired or distracted drivers, providing audible and visual alerts; and in extreme cases, take over the vehicle. The system can distinguish between living entities and objects working through mediums like walls, underwater and underground, which enable the creation of a wide variety of safety and rescue applications. The system’s range is determined by its antennas and repeaters to enable larger coverage. GBT believes that this type of technology can be in the forefront of the wireless solutions arena; particularly, since it’s a wearable-less nature. The company is targeting building a generic prototype and engaging with possible partners to implement a practical application.

 

According to the press release, implementing Metaverse technology into Apollo facilitates the ability to “​​represent physical reality into augmented and virtual reality computerized environments.” A further excerpt from the press release indicates:

 

“[The] Apollo system is targeted to be used for medical, security, and surveillance applications, and equipping it with Metaverse imaging technology, will offer major advancements within its cinematic capabilities."

 

Elsewhere, digital healthcare firm Babylon Holdings Limited (NYSE:BBLN) recently announced the launch of its AI-powered triage tool in Rwanda, as part of a 10-year partnership with the Government of Rwanda to build Africa’s first digital-first universal healthcare system. This AI-powered triage tool helps nursing staff by generating relevant questions, collecting information and providing insight, thus streamlining the entire triage process. Paula Musoni, Babylon’s Minister of ICT & Innovation, explained:

 

"The use of technology to deliver government services to Rwandans citizens has been at the core of the national ICT strategy. Whilst Rwanda has done extremely well in applying ICT to deliver most government services, the introduction of Babylon AI allows us to augment human capacity in a chronically understaffed sector that has been put under even more pressure due to the pandemic. Through this technology, Babyl is elevating the quality of treatment for every online patient irrespective of where they are in the country."

 

GE Healthcare, the $17 billion healthcare business subsidiary of General Electric (NYSE:GE), recently signed a letter of intent to collaborate to advance precision diagnosis and treatment of lung cancer with Optellum. Optellum is a private firm, described in the press release as the “leader in AI decision support for the early diagnosis and optimal treatment of lung cancer.” Ben Newton, General Manager, Oncology Solutions, at GE Healthcare, said:

 

"The precise diagnosis of lung cancer can greatly improve patient prognosis. The integration of imaging and medical device data from the Edison Platform with AI-enabled solutions like the one offered by the Optellum Virtual Nodule Clinic has the potential to streamline clinician workflows and advance our goal of making precision healthcare, taking the right action at the right time for every patient, at scale, as widely accessible as possible."

 

Royal Philips (NYSE:PHG) recently launched new AI-enabled innovations in Magnetic Resonance Imaging (MRI), at the Radiological Society of North America (RSNA) annual meeting, designed to “speed up MR exams, streamline workflows, optimize diagnostic quality, and help ensure the efficiency and sustainability of radiology operations.” Arjen Radder, General Manager of MR at Philips, said:

 

“At this year’s RSNA, we are focused on introducing scalable high performance MR systems to the imaging enterprise, with intelligent software built in to automate tasks to help relieve the burden on radiology staff and departments. With AI-driven smart connected systems, optimized workflows, and integrated clinical solutions, our goal is to deliver high quality diagnostic images while also improving radiology department productivity by relieving radiologists of burdensome routine tasks so they have more time to take care of their patients.”

 

While COVID-19 has undoubtedly amplified adoption and innovation of artificial intelligence technologies within the healthcare sector, AI is demonstrably well on its way to continue to develop as an integral part of the market after the pandemic.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

Get more Technology stock investor ideas - news, articles, podcasts and stock directories

 

New #Stocks to Watch at Investor Ideas (NYSE: $SG) (Nasdaq: $PTLO), (NYSE: $LTH), (Nasdaq: $VLCN), (NYSE: $BFLY) (NYSE: $IRNT)

 New #Stocks to Watch at Investor Ideas (NYSE: $SG) (Nasdaq: $PTLO), (NYSE: $LTH), (Nasdaq: $VLCN), (NYSE: $BFLY) (NYSE: $IRNT)

 

 

Point Roberts WA, Delta BC, December 17, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Food & Beverage, Sports, Automotive, Medical Devices and Cybersecurity. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at https://www.investorideas.com/news/2021/main/12171Stocks.asp

 

This week’s new food and beverage companies are involved in restaurant operations, functional beverages, gluten/grain-free foods and wine marketing and distribution.

 

The latest sports company operated fitness centers while the newest Automotive company is the the first all-electric, powersports company.

 

Finally, the latest medical device company has created the world’s first handheld, single-probe whole-body ultrasound system while the newest cybersecurity is delivering the first-ever Collective Defense platform operating at scale.

 

New Stocks Added to Food & Beverage Stocks Directory:

Sweetgreen, Inc. (NYSE:SG) passionately believes that real food should be convenient and accessible to everyone. Every day, across its 140+ restaurants, their 5,000 team members create plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing. Sweetgreen strongly believes in harnessing the power of technology to enhance the customer experience, and leverages their app to create an omnichannel experience to meet their customers where they are. Sweetgreen’s strong food ethos and investment in local communities have enabled them to grow into a national brand with a mission to build healthier communities by connecting people to real food.

 

Portillo's Inc. (Nasdaq:PTLO) In 1963, Dick Portillo invested $1,100 into a small trailer to open the first Portillo’s hot dog stand in Villa Park, IL, which he called “The Dog House.” Years later, Portillo’s has grown to include restaurants in more than 67 locations across nine states. Portillo’s is best known for its Chicago-style hot dogs, Italian beef sandwiches, char-grilled burgers, fresh salads and famous chocolate cake. Portillo’s Home Kitchen is the company’s fast-growing catering business. Portillo’s also ships food to all 50 states via its website.

 

First Watch Restaurant Group, Inc. (Nasdaq:FWRG) is an award-winning Daytime Dining restaurant concept serving made-to-order breakfast, brunch and lunch using fresh ingredients. A recipient of hundreds of local “Best Breakfast” and “Best Brunch” accolades, First Watch’s award winning chef-driven menu includes elevated executions of classic favorites for breakfast, lunch and brunch along with First Watch-specific specialties such as our protein-packed Quinoa Power Bowl®, Farmstand Breakfast Tacos, Avocado Toast, Morning Meditation (juiced in-house daily), our Vodka Kale Tonic, Chickichangas and our famous Million Dollar Bacon. In 2021, First Watch was recognized as FSR Magazine’s Best Menu and as the fastest-growing full-service restaurant chain based on unit growth. There are more than 425 First Watch restaurants in 28 states, and the restaurant concept is majority owned by Advent International, one of the world’s largest private-equity firms.

 

Winc, Inc. (NYSE:WBEV) is one of the fastest growing at-scale beverage companies in the United States with a successful national portfolio of brands fueled by an omni-channel distribution network. Winc's unique digital-first marketing strategy and platform, Winc.com, drive e-commerce, deep customer connections, and data analytics, which we leverage across our expanding network of wholesale and retail partners to develop and scale brands, propelling its powerful omni-channel growth strategy.

 

Vita Coco Company, Inc. (Nasdaq: COCO) was co-founded in 2004 by co-CEO Michael Kirban and Ira Liran. Pioneers in the functional beverage category, The Vita Coco Company’s brands include the leading coconut water, Vita Coco; clean energy drink Runa; sustainable enhanced water, Ever & Ever; and protein-infused water, PWR LIFT. With its ability to harness the power of people and plants, and balance purpose and profit, The Vita Coco Company has created a modern beverage platform built for current and future generations.

 

Real Good Food Company, Inc. (NasdaqGM: RGF)         Founded in 2016, Real Good Foods believes there is a better way to enjoy our favorite foods. Its brand commitment, “Real Food You Feel Good About Eating,” represents the Company’s strong belief that, by eating its food, consumers can enjoy more of their favorite foods and, by doing so, live better lives as part of a healthier lifestyle. Its mission is to make craveable, nutritious comfort foods that are low in carbohydrates, high in protein, and made from gluten- and grain-free real ingredients more accessible to everyone, improve human health, and, in turn, improve the lives of millions of people. Real Good Foods offers delicious options across breakfast, lunch, dinner, and snacking occasions available in over 16,000 stores nationwide, including Walmart, Costco, Kroger, and Target, and directly from its website.

 

New Stocks Added to Sports Stocks Directory:

Life Time Group Holdings, Inc. (NYSE: LTH) Over nearly 30 years, Life Time (NYSE: LTH) has reshaped the way consumers approach their health through omnichannel, healthy way of life communities that address all aspects of healthy living, healthy aging and healthy entertainment. More than 30,000 Life Time professionals are dedicated to providing the best programs and experiences at more than 150 Life Time athletic resort destinations in the United States and Canada, and via a complementary, comprehensive digital platform and portfolio of iconic athletic events – all with the objective of inspiring healthier, happier lives.

 

New Stocks added to Automotive Stocks Directory:

Volcon, Inc. (Nasdaq: VLCN) is the first all-electric, powersports company producing high quality off-road vehicles. Based in Round Rock, Texas, Volcon joins many major electric vehicle manufacturers near Austin, Texas, an area that is poised to become the electric vehicle capital of the world. Volcon was founded with the mission to enhance the outdoor experience while reducing the industry's environmental footprint so that adventurers and workers alike can enjoy the outdoors and preserve it for generations to come. Volcon produces all-electric, off-road vehicles that are designed to elevate the adventure experience and help people get things done at work and on the home front.

Volcon's first product, the innovative Grunt combines a fat tire physique with high-torque electric power and a near-silent drive train which started shipping in September of 2021. Future models include the Runt, which is a youth-sized version of the groundbreaking Grunt. The Stag and Beast will be Volcon's venture into the rapidly expanding world of UTVs and coming in future years as the company continues to expand.

 

New stocks added to Medical Device Stocks Directory:

Butterfly Network, Inc. (NYSE: BFLY) Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network has created the world’s first handheld, single-probe whole-body ultrasound system using its patented Ultrasound-on-Chip™ semiconductor technology. Butterfly’s mission is to democratize medical imaging and contribute to the aspiration of global health equity, including for the 4.7 billion people around the world lacking access to ultrasound. Butterfly is paving the way for earlier detection and remote management of health conditions around the world. The Butterfly iQ+ and Butterfly iQ+ Vet can be purchased today by healthcare practitioners and veterinarians, respectively, in the United States, Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. Butterfly iQ+ is a prescription device intended for trained and qualified healthcare professionals only.

 

New stocks added to Cybersecurity Stocks Directory:

IronNet, Inc. (NYSE: IRNT) Founded in 2014 by GEN (Ret.) Keith Alexander, IronNet, Inc. is a global cybersecurity leader that is transforming how organizations secure their networks by delivering the first-ever Collective Defense platform operating at scale. Employing a number of former NSA cybersecurity operators with offensive and defensive cyber experience, IronNet integrates deep tradecraft knowledge into its industry-leading products to solve the most challenging cyber problems facing the world today.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 

 

 

 

 Investorideas Wishes Everyone a Safe and Happy Holiday Season!